Application History
6 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 12, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Nov 11, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 10, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 25, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Aug 25, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 21, 2025 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemicals for use in industry and science; biochemicals, including polypeptides and antibodies for scientific, laboratory or research purposes; polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; ion channel modulating antibodies, including antagonists or agonists for scientific, laboratory or research purposes; ion channel modulating antibodies, including antagonists or agonists for use in the manufacture of pharmaceuticals and drugs; antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) for scientific, laboratory or research purposes; antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) for use in the manufacture of pharmaceuticals and drugs; antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs.
Class 005
Pharmaceuticals and pharmaceutical preparations; drugs; antibodies for medical use; pharmaceuticals, drugs and pharmaceutical preparations incorporating antibodies, ion channel modulating antibodies including antagonists or agonists, antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) or antibodies derived from mini-protein toxins; vaccines.
Class 042
Scientific and technological services and research and design relating thereto; drug discovery and drug development services; conducting or providing research and development services for others in the field of antibodies; laboratory services relating to the production of antibodies, ion channel modulating antibodies including antagonists or agonists, antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) or antibodies derived from mini-protein toxins; antibody engineering; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; information, advisory and consultancy services in relation to all of the aforesaid.
Class 044
Medical services; medical testing, analysis and diagnostic services in the field of antibodies; medical services connected with the treatment of diseases through the use of antibodies, ion channel modulating antibodies including antagonists or agonists, antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) or antibodies derived from mini-protein toxins, or pharmaceuticals, drugs and pharmaceutical preparations derived from the aforesaid; information, advisory and consultancy services in relation to all of the aforesaid.
Additional Information
Pseudo Mark
KNOT BODY
Classification
International Classes
001
005
042
044